인도 -
영어 -
Central Drugs Standard Control Organization
pentazen 10 tab
ind-swift - pentazocine,paracetamol - tab - 15,500;mg - 10
인도 -
영어 -
Central Drugs Standard Control Organization
penzyl 10ml vial
svizera - pentazocine - vial - 30 mg/ml - 10ml
인도 -
영어 -
Central Drugs Standard Control Organization
penzyl 50*1ml inj
svizera - pentazocine - inj - 30 mg/ml - 50*1ml
인도 -
영어 -
Central Drugs Standard Control Organization
riddof 10*1ml inj
neon - pentazocine - inj - 30mg - 10*1ml
이스라엘 -
영어 -
Ministry of Health
fenta 12
rafa laboratories ltd - fentanyl - patches - fentanyl 12.5 mcg/hour - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy, who have demonstrated opioid tolerance.
이스라엘 -
영어 -
Ministry of Health
m.i.r. 15
rafa laboratories ltd - morphine sulfate - tablets - morphine sulfate 15 mg - morphine - morphine - for the relief of moderate to severe pain.
이스라엘 -
영어 -
Ministry of Health
m.i.r. 30
rafa laboratories ltd - morphine sulfate - tablets - morphine sulfate 30 mg - morphine - morphine - for the relief of moderate to severe pain.
이스라엘 -
영어 -
Ministry of Health
fenta 25
rafa laboratories ltd - fentanyl - patches - fentanyl 25 mcg/hour - fentanyl - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.
이스라엘 -
영어 -
Ministry of Health
fenta 75
rafa laboratories ltd - fentanyl - patches - fentanyl 75 mcg/hour - fentanyl - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.
이스라엘 -
영어 -
Ministry of Health
fenta 100
rafa laboratories ltd - fentanyl - patches - fentanyl 100 mcg/hour - fentanyl - fentanyl - management of chronic pain and intractable pain requiring opioid analgesia.fenta should only be used in patients who are already receiving opioid therapy who have demonstrated opioid tolerance.